R

TransCode Therapeutics
D

RNAZ

1.77000
USD
0.05
(2.91%)
مغلق
حجم التداول
355
الربح لكل سهم
-9
العائد الربحي
-
P/E
-0
حجم السوق
29,967,408
المقالات
المزيد

العنوان: TransCode Therapeutics Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.